Corvus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.38-$26.95 |
Market Cap | $1.3B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.55 |
News
See moreYahoo Finance • 23 days ago
Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
Corvus (CRVS) Q4 2025 Earnings Call Transcript
Yahoo Finance • 2 months ago
Corvus outlines cash runway into Q2 2028 and targets mid-2027 Phase II readout for soquelitinib in atopic dermatitis
Yahoo Finance • 5 months ago
Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial
About
CEO | Dr. Richard A. Miller M.D. |
Address | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 37 |